Current Options for the Diagnosis, Staging and Therapeutic Management of Colorectal Cancer
- PMID: 26674429
- PMCID: PMC4645570
- DOI: 10.1159/000354995
Current Options for the Diagnosis, Staging and Therapeutic Management of Colorectal Cancer
Abstract
Background: Colorectal cancer (CRC) is the one of the most common malignancies and is a leading cause of cancer death worldwide. The incidence of mortality from CRC has decreased in Western countries because of earlier diagnosis and improved treatment modalities; however, mortality is still increasing in most other regions of the world.
Summary: Progress in the development of imaging modalities has enabled more accurate staging based on the TNM classification. The therapeutic management of CRC should involve a multi-modal approach, including high-quality surgery and an optimal choice of chemotherapy and radiotherapy regimens according to disease characteristics and patient preferences. Even in the case of metastatic disease, the optimal multi-modal treatments could achieve potential cure or long-term survival benefit in some patients. The aim of this review is to present current options regarding the diagnosis, staging and treatment management for CRC based on published research reports and the current management guidelines.
Keywords: Colorectal cancer; Imaging modality; Therapeutic management.
Similar articles
-
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.Ann Oncol. 2012 Oct;23(10):2479-2516. doi: 10.1093/annonc/mds236. Ann Oncol. 2012. PMID: 23012255
-
Pulmonary nodules and metastases in colorectal cancer.Dan Med J. 2016 Jan;63(1):B5190. Dan Med J. 2016. PMID: 26726908
-
Review on the immunotherapy strategies against metastatic colorectal carcinoma.Immunotherapy. 2016 Oct;8(10):1245-61. doi: 10.2217/imt-2016-0045. Immunotherapy. 2016. PMID: 27605072 Review.
-
Colorectal cancer: Recent advances in management and treatment.World J Clin Oncol. 2024 Sep 24;15(9):1136-1156. doi: 10.5306/wjco.v15.i9.1136. World J Clin Oncol. 2024. PMID: 39351451 Free PMC article. Review.
-
Colon Cancer Screening - Is It Time Yet?J Coll Physicians Surg Pak. 2017 Jun;27(6):327-328. J Coll Physicians Surg Pak. 2017. PMID: 28689518
Cited by
-
Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study.J Cancer Res Clin Oncol. 2021 May;147(5):1407-1419. doi: 10.1007/s00432-021-03557-y. Epub 2021 Mar 4. J Cancer Res Clin Oncol. 2021. PMID: 33661394 Free PMC article.
-
Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.Med Sci Monit. 2019 Jun 5;25:4176-4185. doi: 10.12659/MSM.914195. Med Sci Monit. 2019. PMID: 31164625 Free PMC article.
-
Carbon-Based Nanomaterials as Drug Delivery Agents for Colorectal Cancer: Clinical Preface to Colorectal Cancer Citing Their Markers and Existing Theranostic Approaches.ACS Omega. 2023 Mar 14;8(12):10656-10668. doi: 10.1021/acsomega.2c06242. eCollection 2023 Mar 28. ACS Omega. 2023. PMID: 37008124 Free PMC article. Review.
-
Introducing novel key genes and transcription factors associated with rectal cancer response to chemoradiation through co-expression network analysis.Heliyon. 2023 Aug 2;9(8):e18869. doi: 10.1016/j.heliyon.2023.e18869. eCollection 2023 Aug. Heliyon. 2023. PMID: 37636389 Free PMC article.
-
Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach.Oncotarget. 2017 Oct 30;8(63):106935-106947. doi: 10.18632/oncotarget.22149. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29291001 Free PMC article.
References
-
- Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765–781. - PubMed
-
- Benson AB, III, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W, Jr, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA. Metastatic colon cancer, version 3. 2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11:141–152. - PubMed
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
-
- Ku G, Tan IB, Yau T, Boku N, Laohavinij S, Cheng AL, Kang YK. de Lima Lopes G Jr Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 2012;13:e470-e481. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources